Search

everythinglearnresearchcommunity

for

Search:↓

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.

RANKL improves the immune response against herpes simplex virus by enhancing T cell activation and could help develop better treatments or vaccines.

New treatments for hair growth disorders are needed due to limited current options and complex hair follicle biology.

Understanding T cells and signaling pathways can lead to better treatments for hair loss.

Immune checkpoint inhibitors can increase the risk of autoimmune skin diseases, especially bullous pemphigoid.

NF-κB signaling is crucial in many diseases and can be targeted for new treatments.

Certain genetic variants linked to immune response increase the risk of alopecia areata in Taiwanese people.

Nitric oxide is important for skin functions and both helps protect against and contributes to skin inflammation and sensitization.

The authors agree more research with proper control groups is needed to understand hair loss.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

IVIG therapy was linked to hair regrowth in two patients with hair loss, but it's not recommended due to its risks and costs.

Skin aging reflects overall body aging and can indicate internal health conditions.

Fish oil improves skin health in people with diabetes and high cholesterol.

Genetic factors, skin barrier, immune function, and obesity influence risk of fungal skin infections.

Restoring microbial balance and using exosome therapies may help treat hair disorders like alopecia and acne.

Alopecia Areata patients have low zinc and high copper levels.

UV radiation causes skin aging by damaging cells and triggering harmful processes.

Special cells can help regrow hair in alopecia areata.

Alopecia is caused by various factors, and new treatments like gene editing and regenerative medicine offer hope for personalized hair regrowth solutions.

CD27 and IL-35 can help diagnose alopecia areata linked to bacterial infections.

Personalized treatments for hair loss focus on specific genetic and biological pathways.

Bioprinting is improving skin models for better testing of skin diseases without using animals.

Arctium lappa L. might help treat immune-related skin diseases, but more research is needed.

Targeting specific cell interactions may help treat skin fibrosis.

Hair loss in males and females is influenced by immune cell interactions, with potential treatments identified.

A rare combination of hair loss and excessive fine hair growth was found in celiac disease patients.

Baricitinib may effectively treat both alopecia areata and immune thrombocytopenia.

Oxidative stress damages hair follicles and worsens hair loss in androgenetic alopecia.

Children with celiac disease often have skin issues, best managed with a gluten-free diet and sometimes medication.

Advancements in skin regeneration focus on stem cells, nanotechnology, and bioengineered skin to improve healing and reduce scarring.